Does furosemide improve renal function in patients with renal impairment?
| ISRCTN | ISRCTN80628681 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN80628681 |
| Secondary identifying numbers | N0060110641 |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 02/11/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Neil Soni
Scientific
Scientific
Magill Dept of Anaesthetics, 3rd Floor, D Lift
Chelsea & Westminster Hospital
369 Fulham Road
London
SW10 9NH
United Kingdom
| Phone | +44 (0)20 8237 2763 |
|---|---|
| n.soni@imperial.ac.uk |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use contact details to request a participant information sheet |
| Scientific title | Does furosemide improve renal function in patients with renal impairment? |
| Study objectives | Does furosemide improve renal function in patients with renal impairment? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Urological and Genital Diseases: Renal function |
| Intervention | Randomised, controlled trial, parallel design. |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Furosemide |
| Primary outcome measure | Change in creatinine clearance after 24 hours of receiving, or not, furosemide infusion. |
| Secondary outcome measures | Other outcome measures include rate of requirement of renal replacement therapy, peak creatinine, requirement for mineral replacement. |
| Overall study start date | 11/02/2002 |
| Completion date | 31/07/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | 100 |
| Key inclusion criteria | 100 patients, 2 per week. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 11/02/2002 |
| Date of final enrolment | 31/07/2007 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Chelsea & Westminster Hospital
London
SW10 9NH
United Kingdom
SW10 9NH
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.dh.gov.uk/Home/fs/en |
|---|
Funders
Funder type
Government
Chelsea and Westminster Healthcare NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
02/11/2016: No publications found, verifying study status with principal investigator.
